Tumors genetically engineered to produce cytokines will release them locally in a sustained manner, stinulate a host immune cell infiltrate, enhance the recognition of tumor-associated antigens, and generate systemic specific immunity. This hypothesis, which has been supported for various cytokines in several animl tumor models requires direct testing in patients.
Showing the most recent 10 out of 1085 publications